Pediatrix Medical Group, Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $487.8M | $476.2M | $493.8M | $492.9M | $468.8M | $458.4M | $502.4M | $511.2M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $61.3M | $60.3M | $65.7M | $60.8M | $55.7M | $58.6M | $63.6M | $58.1M |
| Operating Income | $56.9M | $41.7M | $48.8M | $68.1M | $59.9M | $32.1M | $39.3M | $33.8M |
| Operating Margin | 11.7% | 8.7% | 9.9% | 13.8% | 12.8% | 7.0% | 7.8% | 6.6% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $54.0M | $38.8M | $45.6M | $87.8M | $55.0M | $28.1M | $33.3M | $25.2M |
| Income Tax Expense | $14.2M | $9.3M | $11.9M | $16.1M | $15.7M | $7.4M | $2.8M | $5.8M |
| Net Income | $39.8M | $29.6M | $33.7M | $71.7M | $39.3M | $20.7M | $30.5M | $19.4M |
| Net Margin | 8.2% | 6.2% | 6.8% | 14.5% | 8.4% | 4.5% | 6.1% | 3.8% |
| EPS (Basic) | $0.50 | $0.37 | $0.41 | $0.85 | $0.46 | $0.25 | $0.37 | $0.23 |
| EPS (Diluted) | $0.49 | $0.36 | $0.40 | $0.84 | $0.46 | $0.24 | $0.37 | $0.23 |
| Shares Outstanding (Basic) | 79.4M | 80.9M | 84.1M | 84.6M | 84.8M | 84.4M | 83.3M | 83.9M |
| Shares Outstanding (Diluted) | 81.4M | 83.1M | 85.3M | 85.6M | 85.5M | 85.4M | 83.3M | 84.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |